Changing the game in Cancer … through Clinical Trials
"The Myth of Data Sharing"
During the last 10 years there has been notable progress in transparency regarding what clinical trials have been performed. Well under 1% of that data has been shared and analyzed beyond the original sponsors. Many challenges have prevented us from realizing the vision of widely shared and linked data that prompts discovery of new biomarkers, patient treatment strategies, understanding of safety concerns, and ultimately improved outcomes for patients. How do we solve these challenges and why do so many remain?
- Donna Smiley, oncology clinical trial participant
- Frank Rockhold, ScM, PhD, PStat®, CSTAT, FASA, FSCT, Professor of Biostatistics and Bioinformatics at Duke University Medical Center, Affiliate Professor of Biostatistics at Virginia Commonwealth University, and Managing Partner of Hunter Rockhold, Inc.